Trials / Conditions / Digestive System Neoplasm

Digestive System Neoplasm

22 registered clinical trials studyying Digestive System Neoplasm — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Target-specific immunoPET Imaging of Digestive System Carcinoma NCT06715839	RenJi Hospital	N/A
Terminated	Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 NCT05980416	Elevation Oncology	Phase 1
Withdrawn	Gastrointestinal Anastomosis Using MonoPlus® Suture NCT04811833	Aesculap AG	—
Recruiting	Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced G NCT06223230	Renmin Hospital of Wuhan University	N/A
Recruiting	OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. NCT04493632	OncoSil Medical Limited	—
Completed	Retrospective Analysis of Colorectal Cancer Screening Results NCT05374369	Creative Biosciences (Guangzhou) Co., Ltd.	—
Terminated	A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) NCT05160168	Theseus Pharmaceuticals	Phase 1 / Phase 2
Unknown	Total Versus Partial Omentectomy in the Treatment of Gastric Cancer NCT05238584	University of Debrecen	N/A
Unknown	Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) NCT04929015	Rutgers, The State University of New Jersey	N/A
Completed	A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China NCT04722055	Creative Biosciences (Guangzhou) Co., Ltd.	—
Unknown	MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Pro NCT04500990	Peking University	—
Completed	Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study NCT04456140	Mayo Clinic	Phase 1
Active Not Recruiting	ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial NCT04084249	Claus Lindbjerg Andersen	N/A
Completed	Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma NCT03559543	Catalysis SL	Phase 2
Completed	Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction NCT03549494	Catalysis SL	Phase 2
Terminated	Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. NCT03724071	Transgene	Phase 1 / Phase 2
Completed	A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cance NCT03535727	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1 / Phase 2
Unknown	C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer NCT04133324	Moroccan Society of Surgery	—
Completed	Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385	Hoffmann-La Roche	Phase 1 / Phase 2
Recruiting	A Clinicobiological Database in Metastatic Digestive Cancers NCT03978078	Institut du Cancer de Montpellier - Val d'Aurelle	N/A
Terminated	131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients NCT02602067	sigma-tau i.f.r. S.p.A.	Phase 1
Terminated	Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients Wi NCT01939210	Albert Einstein College of Medicine	N/A